<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15394-bib-0012">
 <mixed-citation publication-type="journal" id="bjh15394-cit-0012">
  <string-name>
   <surname>Durie</surname>, 
   <given-names>B.G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hoering</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Abidi</surname>, 
   <given-names>M.H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Rajkumar</surname>, 
   <given-names>S.V.</given-names>
  </string-name>, 
  <string-name>
   <surname>Epstein</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kahanic</surname>, 
   <given-names>S.P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Thakuri</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Reu</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Reynolds</surname>, 
   <given-names>C.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Sexton</surname>, 
   <given-names>R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Orlowski</surname>, 
   <given-names>R.Z.</given-names>
  </string-name>, 
  <string-name>
   <surname>Barlogie</surname>, 
   <given-names>B.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Dispenzieri</surname>, 
   <given-names>A.</given-names>
  </string-name> (
  <year>2017</year>) 
  <article-title>Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem‐cell transplant (SWOG S0777): a randomised, open‐label, phase 3 trial</article-title>. 
  <source xml:lang="en">Lancet</source>, 
  <volume>389</volume>, 
  <fpage>519</fpage>–
  <lpage>527</lpage>.
  <pub-id pub-id-type="pmid">28017406</pub-id>
 </mixed-citation>
</ref>
